Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- KINGS COLLEGE LONDON
- University of Oxford;
- King's College London
- AALTO UNIVERSITY
- Heriot Watt University
- The University of Edinburgh;
- UNIVERSITY OF VIENNA
- University of Cambridge;
- University of Liverpool
- University of London
- ;
- Atlantic Technological University;
- City University London
- Nature Careers
- Royal Horticultural Society;
- University of Cambridge
- University of Dundee;
- University of Liverpool;
- 9 more »
- « less
-
Field
-
overburden the capacity limits of 5G networks, making impossible to support the target requirements of spectrum, energy efficiency, latency, and massive connectivity. New technologies that address the looming
-
overburden the capacity limits of 5G networks, making impossible to support the target requirements of spectrum, energy efficiency, latency, and massive connectivity. New technologies that address the looming
-
feedstocks into high value second generation chemicals. The target molecule has varied applications across the food and flavouring, pharmaceuticals and agrichemical industries. The project will be based in
-
human tumours. We have an exciting opportunity for a Postdoctoral Researcher to join the new team at Oxford, utilising in vivo brain tumour models to identify molecular targets underlying tumour
-
for three years. The project "Smart Efficient Compression: Reliability and Energy Targets (SECRET)" funded by Royal Academy of Engineering and Howden Compressors involves research into improving efficiency
-
valuable resource for investigating novel molecular mechanisms underlying gastric cancer pathogenesis, with the goal of identifying new therapeutic targets. You will work closely with academic staff
-
microbial effectors targeted host plant processes. Crucially, the project will exclude the study of plant immunity. The successful candidate will use advanced cell biology, protein biochemistry, and molecular
-
their target antigens and become activated in serious human diseases, including autoimmune disorders, infectious diseases, and cancers. We study how adaptive T cell immunity is developed and/or becomes impaired
-
proteins that regulate many processes, from blood coagulation to extracellular matrix (ECM) homeostasis. Most serpins are inhibitory, and use a covalent mode of inhibition to inhibit their target serine
-
coagulation to extracellular matrix (ECM) homeostasis. Most serpins are inhibitory, and use a covalent mode of inhibition to inhibit their target serine proteinases (1). We and others have suggested serpins